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Liver cirrhosis is the last stage of chronic liver disease that is in the path of the disease can cause 
damage of liver function and/or portal hypertension. The prognosis of liver cirrhosis can be 
assessed by manifestations of liver function disorders with Child Pugh score that include the 
presence or absence of ascites, encephalopathy, bilirubin serum, albumin serum, and prothrombin 
time or INR, while portal hypertension also occurs in patient of cirrhosis can lead the formation of 
esophageal varices. APRI score has platelet count and AST serum as its variable is suspected to 
be related to the Child Pugh score in assessing prognosis of cirrhosis patients. This study purposed 
to find the relation between APRI score (Aspartate Aminotransferase-to-Platelet Ratio Index) and 
Child Pugh score. Purpose of this research is to find the relation between APRI score (Aspartate 
Aminotransferase-to-Platelet Ratio Index) and Child Pugh score and degree of esophageal varices 
in patients with cirrhosis. Method used is a retrospective analytic study with cross sectional 
approach. The data source is secondary source. The sample in this study were patients with liver 
cirrhosis who were diagnosed by a doctor and had complied the inclusion criteria. The data 
obtained was analyzed using ANOVA. 
The result of this study is include 48 cirrhosis patients, male 81,3%, with a mean age 49,98 years. 
The most common cause of cirrhosis is hepatitis B obtained from reactive HBsAg examination in 
33 patients (68,8%). The APRI score was found to have a weak correlation (r = 0.044) and not 
significant (p = 0.868) with the Child Pugh score. The APRI score do not able to assess the 
prognosis in advanced cirrhotic patients. 
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INTRODUCTION 
Cirrhosis of the liver is the last stage of chronic liver disease which in the course of the 
disease can cause impaired liver function and/or portal hypertension1. Impaired liver function is 
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manifested by the presence of icterus due to increased total serum bilirubin, ascites, changes in 
mental status, thrombocytopenia due to decreased thrombopoietin production, increased serum 
aspartate aminotransferase (AST) and alanine transaminase (ALT), and hypoalbuminemia2,3. 
Whereas, portal hypertension results in platelet sequestration in the spleen and the formation of 
esophageal varices. The appearance of complications such as ascites, encephaloplatepatikum, and 
rupture of esophageal varices can increase mortality in cirrhosis patients4. 
The cause of death due to cirrhosis of the liver was ranked 17th out of 235 diseases that 
cause death in the world in 2010, and ranked 11th in the Southeast Asian region5. In Indonesia, on 
average, there are about 3.5% of liver cirrhosis patients out of the total number of patients admitted 
to the Internal Medicine ward of a government hospital6. 
The prognosis of patients with liver cirrhosis can be predicted by using a corneous, one of 
which is Child Pugh score7. Indicators assessed in this score are sites, encephalopathic hepatic, 
total bilirubin, serum albumin, prostrombin time, and INR (International Normalized Ratio) 8. The 
Child Pugh score has a sensitivity and specificity of 77.7% and 63% in assessing prognosis in 
patients with cirrhosis of the liver. The study also showed that the Child Pugh score was a better 
indicator in determining the prognosis of patients with liver cirrhosis compared to the MELD 
(Model for End-Stage Liver Disease) score9. The Child Pugh score is considered the most 
consistent in determining the prognosis of liver cirrhosis patients compared with other scores such 
as MELD scores or serum ALT levels alone10. 
At a later stage, most liver cirrhosis patients will manifest in the form of a decrease in the 
number of platelets that is 70,000-149,000 / µL and an increase in AST levels of 36-175 U / L11. 
Platelet count is one of the variables that is often used in predicting mortality in patients with liver 
cirrhosis10. A score is designed that is the APRI (Aspartate Aminotransferase-to-Platelet Ratio 
Index) score which is considered more objective in determining the presence or absence of 
cirrhosis in patients with chronic liver disease. This score develops on the assumption that 
increasing AST counts and decreasing platelet counts are the most important predictors in 
determining the formation of liver fibrosis in patients with chronic liver disease12. In addition, 
APRI scores can also be used to predict the prognosis in liver cirrhosis patients such as Child Pugh 
and MELD7 scores. Increased APRI scores are associated with worsening Child Pugh scores and 
increase the likelihood of a person experiencing decompensated liver cirrhosis13. 
 
MATERIAL AND METHOD 
 The design of this study was a retrospective analytic cross sectional approach using non-
random techniques by purposive sampling. The data taken is secondary data derived from medical 
records of liver cirrhosis patients in Abdul Wahab Sjahranie Hospital in Samarinda with 48 
patients. Data analysis was done by using ANOVA test. The APRI score is a comparison between 
AST levels and platelet counts obtained from laboratory tests during hospitalization with objective 
cut-off criteria < 0.5 = non-fibrosis; 0.5 - 1.5 = moderate fibrosis; and cut-off > 1.5 = cirrhosis. 
Child Pugh score is score obtained from the assessment of the presence or absence of ascites, 
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encephalopithepatic, bilirubin levels, albumin levels, and prothrombin time or INR obtained from 
resumes and laboratory results while the patient is in the hospital. 
RESULTS AND DISCUSSION 
In this study, 48 samples were found that met the inclusion and exclusion criteria that had been 
set. 
1. Characteristics of Patients with Cirrhosis Liver 
Table 1 Characteristics of Patients with Cirrhosis of the Liver 
 
Characteristic (n) (%) Mean Min. Max. 
Age Total 48 100 49.98 24 77 
Gender 
 
Male 39 81.3    
Female 9 18.8    
HbsAg Reactive 33 68.8    
 Non-Reactive 13 27.1    
 Undefined 2 4.2    
APRI Score Score < 0.5 1 2.1 5.102 0.1 45.6 
 Score 0.5-1.5 14 29.2    
 Score > 1.5 33 68.8    
Child Pugh A 2 4.2    
 B 23 47.9    
 C 23 47.9    
Esophageal Varices Normal 20 41.7    
 Grade 1 5 10.4    
 Grade 2 5 10.4    
 Grade 3 18 37.5    
 
In this study, it was found that the average age of liver cirrhosis patients was 49.98 years with 
the number of male as many as 39 patients (81.3%). The main cause of liver cirrhosis was 68.8% 
of hepatitis B obtained from HBsAg examination. 
The proportion of liver cirrhosis patients according to age that has been presented in table 1 
shows that the mean age of liver cirrhosis patients is 49.98 years. Not much different compared to 
a result of research conducted in Texas which was found that liver cirrhosis patients were 
dominated by the age group above 40 years, 1,798 patients out of 2,017 patients, with an average 
age of 52 years14. This study is also in accordance with research conducted in Medan where the 
mean age of liver cirrhosis patients was 48.5 years15. This can occur because cirrhosis of the liver 
is a chronic disease of the liver with new symptoms and signs that will appear years later after 
prolonged exposure by a risk factor or a history of hepatitis virus infection16. 
Table 1 also shows that the proportion of patients with liver cirrhosis in male is higher (81.3%) 
than female (18.8%). This study is in accordance with research conducted in Manado which found 
that more male were suffering from liver cirrhosis (62.7%) than female (37.7%) 17. Research in 
Singapore also found that liver cirrhosis patients were dominated by men with 360 patients 
(63.4%) out of 564 patients taken as samples18. 
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It is not yet known for sure the cause of male tendency to suffer more cirrhosis of the liver 
than female. However, it is allegedly caused by the position of male as the head of the household 
which required them to work harder and rarely pay attention to their physical and mental health so 
that they tend to be more susceptible to disease. In western countries, men tend to suffer more from 
liver cirrhosis due to the habit of consuming alcohol19. 
Based on research conducted at Abdul Wahab Sjahranie Hospital in Samarinda, it was also 
found that the most common cause of cirrhosis was hepatitis B virus infection as proven by the 
large number of reactive HBsAg results (68.8%). This is in line with research conducted in Manado 
which got the highest cause of liver cirrhosis due to hepatitis B virus infection as much as 37.3% 
and research in Pontianak also found that the most cause of liver cirrhosis was hepatitis B virus 
(35.63%) 17, 20. 
The result in table 1 shows that the highest APRI score is > 1.5 (68.8%) or indicates that the 
patient is in advanced fibrosis or cirrhosis. The average APRI score obtained from this study was 
5.102 with a minimum score of 0.1 and a maximum of 45.6. This result is the same as the research 
conducted in Pontianak which obtained APRI scores with minimum (0.08) and maximum (16.08) 
scores that had a very wide range and were not normally distributed. This very wide range is likely 
due to the small number of research subjects and the presence of diverse etiologies and some data 
not mentioning a history of hepatitis or a history of alcohol consumption20. 
The result in table 1 illustrates that the classification of the highest Child Pugh score was Child 
Pugh B, as many as 23 patients (47.9%) and Child Pugh C as many as 23 patients (47.9%). 
Research conducted by Poernomo (2015) in Yogyakarta also shows that the Child Pugh B class is 
more dominant (61.11%) than the Child Pugh C class (39.89%) as well as in research conducted 
in Manado where Child Pugh C dominate the result of the most type suffered by liver cirrhosis 
patients, as many as 20 people (64.5%), followed by the Child Pugh B of 7 people (22.6%), and 
the Child Pugh A of 3 people (9.7%) 21, 22. 
Research that has been done also shows that people suffering from cirrhosis of the liver 
majorly suffer from large esophageal varices or grade 3, of 18 patients (37.5%) from the 
population. Likewise, in line with the previous research in which it shows that people with liver 
cirrhosis mostly suffer from grade 3 esophageal varices, as many as 47 people (71.2%) 23. 
 
2. The Relationship between APRI (Aspartate Aminotransferase-to-Platelet Ratio Index) 
score and Child Pugh Score 








A B C 
Non-Fibrosis 
(score< 0.5) 
0 1 0 1 
0.868 
0.044 
Moderate Fibrosis 1 6 7 14  
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(score 0.5 – 1.5) 
Cirrhosis 
(score> 1.5) 
1 16 16 33  
Total 2 23 23 48  
 
In this study, it was found that the majority of liver cirrhosis patients were in the APRI score 
group > 1.5 category in the Child Pugh B and C classes as many as 23 people for each 
classification. The results of the analysis of the relationship between APRI scores and Child Pugh 
scores obtained a weak correlation (r = 0.044) and is insignificant as indicated by a p value of 
0.868. The value of α is 0.05. This indicates that there is no significant relationship between APRI 
scores and Child Pugh scores seen from p values that are greater than α values. 
It also stated that in assessing the development of annual liver cirrhosis the APRI score did 
not have a significant relationship with the severity of liver cirrhosis (p = 0.228). Previous studies 
also showed the value of limited APRI changes in predicting the development of liver cirrhosis24. 
However, different from research in Karnataka in which it also found a significant relationship 
between APRI scores and Child Pugh scores (p value <0.001). In this study, it was also found that 
the higher the APRI score, the higher the Child Pugh class of the patient would be, so that the 
APRI score can also be used to predict mortality in liver cirrhosis patients7. Research in Pontianak 
also found that the statistical test results of APRI scores and the severity of liver cirrhosis as 
measured by Child Pugh scores showed a significant relationship (p = 0.005) 20. 
The APRI score uses a variable that is thought to be the most important predictor in 
determining the presence or absence of fibrosis in patients with chronic liver disease, namely AST 
levels and platelet counts12. Increased AST levels and decreased platelet counts can be a sign that 
liver damage is in the advanced phase11. 
Although the main mechanism of decreasing platelets or thrombocytopenia in patients with 
chronic liver disease is the presence of platelet askuesteration in the spleen and a decrease in the 
production of thrombopoietin in the liver, platelet reduction can also be caused by various other 
factors, namely cirrhosis of the coagulopathy, bone marrow suppression by chronic infection of 
the hepatic C virus and reduction in thrombopoietin production in the liver, but the decrease in 
platelets can also be caused by various other factors, such as cirrhosis of coagulopathy, suppression 
of bone marrow by chronic infection of the hepatitis C, and the liver anti-cancer agents as well as 
antiviral treatment with interferon-based therapy can also contribute to the development of 
thrombocytopenia in cirrhosis patients25. 
In addition, the development of a state of fibrosis in the liver can also reduce AST clearance 
and injure mitochondria so that it will increase serum AST12 levels. AST is an enzyme that can be 
found in the liver that functions as a catalyst for aspartate and alpha-ketoglutarate to oxaloacestates 
and gluamates. Although AST enzymes are mainly found in liver cells, some cells such as red 
blood cells, heart cells, muscle cells, pancreas, and kidneys can also produce these enzymes26. 
In patients with advanced liver disease or atarosis, there is often a subtle change in laboratory 
values to within the normal range. Therefore, laboratory studies cannot be used as a single 
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screening tool in assessing patient prognosis. By identifying risk factors, physical examination, 





There is no relationship between APRI score and Child Pugh score on liver cirrhosis patients 
at Abdul Wahab Sjahranie Hospital in Samarinda so that the APRI score cannot replace the Child 
Pugh score in determining the prognosis of liver cirrhosis patients. 
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